|
Cours en clôture
30/09/2026
|
Varia. 5j.
|
Varia. 1 janv.
|
|
3,270 CNY
|
+0,93%
|
 |
-1,51%
|
+1,55%
|
|
21/09 |
Realcan Pharmaceutical Group Co., Ltd.(XSEC:002589) added to S&P Global BMI Index
| | |
20/08 |
Realcan Pharmaceutical Group Co., Ltd. Approves the Election of Lv Kaiqiang and Wu Bin as Independent Director
| | |
20/08 |
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026
| | |
19/05 |
Realcan Pharmaceutical Group Co., Ltd. Approves Cash Dividend for 2025 for A shares, Payable on 30 June 2026
| | |
24/04 |
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026
| | |
23/04 |
Realcan Pharmaceutical Group Co., Ltd. announces Annual dividend, payable on June 30, 2026
| | |
22/04 |
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025
| | |
07/11 |
Tranche Update on Realcan Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on November 11, 2024.
| | |
07/11 |
Realcan Pharmaceutical Group Co., Ltd.'s Equity Buyback announced on November 11, 2024, has closed with 34,638,659 shares, representing 2.31% for CNY 101.48 million.
| | |
29/10/25 |
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025
| | |
13/10/25 |
Tranche Update on Realcan Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on November 11, 2024.
| | |
25/08/25 |
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025
| | |
03/07/25 |
Realcan Pharmaceutical Vice President Detained
| | |
03/07/25 |
Tranche Update on Realcan Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on November 11, 2024.
| | |
03/06/25 |
Yanquan No. 8 Private Securities Investment Fund, a fund managed by Jiaxing Yanquan Investment Partnership LLP cancelled the acquisition of 5.05% stake in Realcan Pharmaceutical Group Co., Ltd. from Zhang Renhua for approximately CNY 160 million.
| | |
03/06/25 |
Realcan Pharmaceutical Group Shareholder Nixes Share Transfer Deal
| | |
19/05/25 |
Realcan Pharmaceutical Group Co., Ltd. Approves Cash Dividend for 2024
| | |
16/05/25 |
Declaration of Voting Results by Realcan Pharmaceutical Group
| | |
06/05/25 |
Realcan Pharmaceutical Group Receives Shareholder Proposal from Renhua Zhang
| | |
29/04/25 |
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025
| | |
24/04/25 |
Realcan Proposes Final Cash Dividend for 2024
| | |
23/04/25 |
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024
| | |
08/04/25 |
Tranche Update on Realcan Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on November 11, 2024.
| | |
07/04/25 |
Realcan Pharmaceutical Releases Correction on Auditor's Penalties; Shares Slump 10%
| | |
24/02/25 |
Realcan Pharmaceutical to Buy Majority Stake in First-Class Medical Device Maker for 151 Million Yuan
| |
Aucun résultat pour cette recherche Sélectionnez votre édition Toutes les informations financières adaptées au niveau national | 
